ProShare Advisors
MBII

ProShare Advisors’s Marrone Bio Innovations, Inc. MBII Stock Holding History

ProShare Advisors’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-18,983
Closed -$20K – 2260
2022
Q1 		$20K Sell
18,983
-3,136
-14% -$2.37K ﹤0.01% 2175
2021
Q4 		$15K Buy
22,119
+9,280
+72% +$7.51K ﹤0.01% 2337
2021
Q3 		$12K Sell
12,839
-13,152
-51% -$15.8K ﹤0.01% 2001
2021
Q2 		$43K Buy
25,991
+7,461
+40% +$12.5K ﹤0.01% 2364
2021
Q1 		$39K Buy
18,530
+3,166
+21% +$6.58K ﹤0.01% 2240
2020
Q4 		$19K Buy
+15,364
New +$18.3K ﹤0.01% 2089

Other funds holding MBII

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

ProShare Advisors's MBII Position: Q2 2022 in Review

ProShare Advisors sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2022, closing a stake of 18,983 shares — an estimated $20K sold.

ProShare Advisors first reported a position in MBII in Q4 2020 and held it in 6 quarters. The position peaked at $43K in Q2 2021. 62 funds tracked by Wall St. Rank hold MBII as of Q2 2022.

  • ProShare Advisors reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2022 after selling out during the quarter.
  • ProShare Advisors sold 18,983 Marrone Bio Innovations, Inc. shares in Q2 2022, an estimated $20K.
  • ProShare Advisors first reported a position in Marrone Bio Innovations, Inc. in Q4 2020 and held it in 6 quarters.
  • ProShare Advisors's Marrone Bio Innovations, Inc. position peaked at $43K in Q2 2021.
  • 62 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2022.

Based on ProShare Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.